Drugs / Tetanus booster
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT06639607 Background | Sep 2026 → Aug 2031 | ependymoma, medulloblastoma | Washington University School of Medicine | Suspended | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tetanus booster | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06639607 ↗ |
| Modality | Vaccine | “Td pre-conditioning vaccine” NCT06639607 ↗ |